While 2017 has been a great year for many ASX companies, others have not done so well.
Here's a look at 3 shares that haven't performed so well over the past 12 months.
iSentia Group Ltd (ASX: ISD)
The iSentia Group Ltd share price has by dropped more than 50 per cent in the past year with shares in the company now trading at around $1.34.
The media monitoring company, with a market cap of about $268 million, reported revenue of $155.1 million for financial year (FY) 2017, down 1 per cent on the previous year.
The iSentia Group also reported EBITDA of $41.5 million for FY 2017, down 19 per cent on the previous year.
And, with the company forecasting EBITDA in the range of $32 million to $36 million for FY 2018, it doesn't look like things are getting better in the near future for iSentia.
Mayne Pharma Group Ltd (ASX: MYX)
The Mayne Pharma Group Ltd share price has shed more than 50 per cent this year.
But Mayne expects things to turn around in the next couple of years with 6 products anticipated for approval in FY 2018 and 8 potential product launches in 2019.
Mayne shares are now trading at about 63 cents but UBS analysts have tipped the pharmaceutical company's share price to push past $1 in the next 12 months.
Thorn Group Ltd (ASX: TGA)
It hasn't been a great year for Thorn Group Ltd shareholders who have seen their stock in the company drop by nearly 60 per cent.
Thorn, with a market cap down to $120 million, has seen its share price sink from above $3 in early 2015 to its current price of 75 cents.
The financial services company reported a loss of $9.7 million for the six month period ended 30 September, down from a profit of $15 million announced for the prior corresponding period.
If you're interested in checking out some shares that look at bit more promising than those mentioned above, you may want to have a read of this…
